AZTA
Azenta, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum-inputs (vergelijkbare managers):
breedte van houders -5.9% ·
aandelenstroom -7.4% ·
netto nieuwe posities -6.2%
· formule
Brede distributie: dalende aandelen en minder houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | +1 | 120.54K | $3.93M | +1 | n/a |
| Q2 2026 | 95 | +4 | 31.71M | $809.28M | +12 | −7 |
| Q1 2026 | 93 | -11 | 30.54M | $644.99M | +6 | −17 |
| Q4 2025 | 103 | -1 | 32.89M | $1.09B | +1 | −2 |
| Q3 2025 | 16 | -1 | 19.69M | $565.39M | n/a | −1 |
| Q2 2025 | 14 | 0 | 18.89M | $581.53M | +1 | −1 |
| Q1 2025 | 11 | 0 | 5.08M | $176.05M | +1 | −1 |
| Q4 2024 | 11 | +1 | 5.23M | $261.74M | +1 | n/a |
| Q3 2024 | 9 | +1 | 2.97M | $143.74M | +1 | n/a |
| Q2 2024 | 8 | n/a | 3.27M | $172.22M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 6.90M | -8.0% | $198.28M | 0.0% | ▼ Trim | 2 | SEC ↗ ×17 |
| 2 | The Vanguard Group ✦ (passief) | 4.44M | -2.7% | $127.50M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passief) | 1.71M | -4.7% | $49.07M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.70M | +41.6% | $48.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 1.02M | -4.0% | $29.34M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 6 | JPMorgan Chase ✦ | 946.63K | n/a | $27.19M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 7 | Morgan Stanley ✦ | 941.36K | n/a | $27.04M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 8 | Fisher Asset Management ✦ | 586.29K | -7.6% | $16.84M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 9 | Gotham Asset Management ✦ | 532.30K | +6.2% | $15.29M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 477.39K | n/a | $13.71M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Citadel Advisors ✦ | 160.71K | -84.8% | $4.62M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 12 | D. E. Shaw & Co. ✦ | 136.76K | -27.3% | $3.93M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 63.20K | +182.4% | $1.78M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 14 | T. Rowe Price ✦ | 39.13K | +7.3% | $1.12M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 19.60K | +168.2% | $562,912 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Fidelity (FMR) ✦ | 12.16K | -13.3% | $349,198 | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Marshall Wace | $9.39M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 256 houders, 52.74M aandelen, $1.06B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.